Drugs Made In America Acquisition II Corp. Unit (DMIIU) financials · $140.2M cap
Lician Pro · $19.99/mo or $149/yrCompare AAPL vs MSFT
Drugs Made In America Acquisition II Corp. Unit (DMIIU) $140.2M cap.
| Line | FY2025 | FY2024 |
|---|---|---|
| Operating Income | -$488.4K | -$151.7K |
| Net Income | $4.19M | -$151.7K |
| Line | FY2025 |
|---|---|
| Total Assets | $505.0M |
| Current Assets | $26.0K |
| Total Liabilities | $17.8M |
| Current Liabilities | $300.9K |
| Shareholders' Equity | -$17.8M |
| Retained Earnings | -$17.8M |
| Line | FY2025 | FY2024 |
|---|---|---|
| Operating Cash Flow | -$1.02M | -$194.3K |
| Investing Cash Flow | -$500.0M | N/A |
| Financing Cash Flow | $501.0M | $211.3K |
FAQ
What is DMIIU P/E and revenue?
Drugs Made In America Acquisition II Corp. Unit (DMIIU) $140.2M cap.
What is DMIIU revenue?
DMIIU income-statement cache has no revenue figure yet.
Is DMIIU profitable?
Drugs Made In America Acquisition II Corp. Unit last cached net income is $4.19M (FY2025).
What are DMIIU total assets?
Drugs Made In America Acquisition II Corp. Unit last cached total assets are $505.0M (FY2025).
What is DMIIU free cash flow?
No cached cash-flow row for DMIIU yet.
Not investment advice. Cached statements, not a live tape.